Brenntag (ISIN DE000A1DAHH0), the global market leader in chemicals and ingredients distribution, today presented financial results for the first quarter of 2024 below the Group’s ambitions. Brenntag’s performance in both divisions was impacted by a challenging market environment as well as pricing pressures in various markets and industries. The encouraging sequential recovery of volumes, especially in the Essentials division, could not fully offset the lower sales prices, as … [Read more...] about Brenntag reports first quarter 2024 results, impacted by challenging market environment – Group expects to benefit from improving conditions in second half of 2024
brenntag
Brenntag Specialties signs an exclusive distribution agreement with Greenyn Biotechnology to serve pharma customers in the Asia Pacific
Exclusive distribution agreement covers plant extract products for the complementary medicine segment Brenntag, the global market leader in chemicals and ingredients distribution, today announced the signing of the distribution agreement with Greenyn Biotechnology, covering a range of innovative and scientifically proven solutions such as Insumate® bitter melon peptides, Antromax® Antrodia Cinnamomea and Zymologist® fermented fruit and vegetable extract. Greenyn Biotechnology … [Read more...] about Brenntag Specialties signs an exclusive distribution agreement with Greenyn Biotechnology to serve pharma customers in the Asia Pacific